Mingchen Historical Income Statement

002919 Stock

16.48 0.14 0.84%

Historical analysis of Mingchen Health income statement accounts such as Interest Expense of 4.4 M, Selling General Administrative of 18.6 M or Selling And Marketing Expenses of 802.6 M can show how well Mingchen Health Co performed in making a profits. Evaluating Mingchen Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mingchen Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Mingchen Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mingchen Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Mingchen Health Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Mingchen Income Statement Analysis

Mingchen Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mingchen Health shareholders. The income statement also shows Mingchen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Mingchen Health Income Statement Chart

At present, Mingchen Health's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.4 M, whereas Selling General Administrative is forecasted to decline to about 18.6 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Mingchen Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Mingchen Health Co minus its cost of goods sold. It is profit before Mingchen Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Mingchen Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mingchen Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Mingchen Health Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Interest Expense	1.9M	3.7M	4.2M	4.4M
Depreciation And Amortization	50.3M	175.3M	201.6M	211.7M

Interest Expense Depreciation And Amortization

Mingchen Health income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.86	0.02	0.98	0.99	1.0	0.99	0.27	0.56	0.97	0.79	0.99	0.25	-0.97	0.4	-0.87	0.88	-0.87	-0.77	0.2	0.34	1.0
Interest Expense	0.86		0.36	0.85	0.82	0.85	0.82	0.16	0.44	0.82	0.56	0.85	0.15	-0.85	0.29	-0.81	0.75	-0.7	-0.7	0.15	0.38	0.86
Selling General Administrative	0.02	0.36		0.06	-0.08	0.0	-0.06	-0.37	-0.28	-0.09	-0.26	0.04	-0.38	-0.09	-0.3	-0.19	0.0	0.04	-0.02	-0.06	-0.03	0.04
Selling And Marketing Expenses	0.98	0.85	0.06		0.98	0.98	0.98	0.1	0.42	0.9	0.78	0.99	0.08	-0.96	0.23	-0.85	0.84	-0.84	-0.7	0.2	0.17	0.99
Total Revenue	0.99	0.82	-0.08	0.98		1.0	1.0	0.29	0.57	0.96	0.83	0.99	0.28	-0.94	0.41	-0.86	0.89	-0.88	-0.72	0.26	0.32	0.99
Gross Profit	1.0	0.85	0.0	0.98	1.0		1.0	0.27	0.55	0.96	0.81	1.0	0.25	-0.95	0.39	-0.88	0.9	-0.89	-0.73	0.26	0.32	0.99
Other Operating Expenses	0.99	0.82	-0.06	0.98	1.0	1.0		0.24	0.52	0.94	0.83	0.99	0.22	-0.94	0.36	-0.86	0.89	-0.89	-0.69	0.27	0.26	0.99
Operating Income	0.27	0.16	-0.37	0.1	0.29	0.27	0.24		0.9	0.51	0.37	0.18	1.0	-0.17	0.98	-0.24	0.42	-0.36	-0.42	0.15	0.93	0.2
Ebit	0.56	0.44	-0.28	0.42	0.57	0.55	0.52	0.9		0.74	0.69	0.47	0.89	-0.51	0.95	-0.49	0.61	-0.58	-0.66	0.09	0.88	0.51
Ebitda	0.97	0.82	-0.09	0.9	0.96	0.96	0.94	0.51	0.74		0.8	0.93	0.49	-0.91	0.61	-0.83	0.88	-0.86	-0.82	0.19	0.55	0.94
Cost Of Revenue	0.79	0.56	-0.26	0.78	0.83	0.81	0.83	0.37	0.69	0.8		0.8	0.34	-0.78	0.49	-0.7	0.75	-0.79	-0.58	0.22	0.31	0.79
Total Operating Expenses	0.99	0.85	0.04	0.99	0.99	1.0	0.99	0.18	0.47	0.93	0.8		0.16	-0.95	0.31	-0.89	0.89	-0.89	-0.68	0.28	0.24	0.99
Income Before Tax	0.25	0.15	-0.38	0.08	0.28	0.25	0.22	1.0	0.89	0.49	0.34	0.16		-0.15	0.98	-0.22	0.4	-0.33	-0.41	0.14	0.92	0.18
Total Other Income Expense Net	-0.97	-0.85	-0.09	-0.96	-0.94	-0.95	-0.94	-0.17	-0.51	-0.91	-0.78	-0.95	-0.15		-0.29	0.81	-0.77	0.79	0.83	-0.03	-0.26	-0.97
Net Income	0.4	0.29	-0.3	0.23	0.41	0.39	0.36	0.98	0.95	0.61	0.49	0.31	0.98	-0.29		-0.41	0.56	-0.5	-0.46	0.24	0.94	0.33
Income Tax Expense	-0.87	-0.81	-0.19	-0.85	-0.86	-0.88	-0.86	-0.24	-0.49	-0.83	-0.7	-0.89	-0.22	0.81	-0.41		-0.96	0.97	0.47	-0.56	-0.37	-0.86
Research Development	0.88	0.75	0.0	0.84	0.89	0.9	0.89	0.42	0.61	0.88	0.75	0.89	0.4	-0.77	0.56	-0.96		-0.98	-0.47	0.61	0.47	0.86
Tax Provision	-0.87	-0.7	0.04	-0.84	-0.88	-0.89	-0.89	-0.36	-0.58	-0.86	-0.79	-0.89	-0.33	0.79	-0.5	0.97	-0.98		0.46	-0.6	-0.38	-0.85
Net Interest Income	-0.77	-0.7	-0.02	-0.7	-0.72	-0.73	-0.69	-0.42	-0.66	-0.82	-0.58	-0.68	-0.41	0.83	-0.46	0.47	-0.47	0.46		0.39	-0.49	-0.76
Interest Income	0.2	0.15	-0.06	0.2	0.26	0.26	0.27	0.15	0.09	0.19	0.22	0.28	0.14	-0.03	0.24	-0.56	0.61	-0.6	0.39		0.13	0.17
Net Income From Continuing Ops	0.34	0.38	-0.03	0.17	0.32	0.32	0.26	0.93	0.88	0.55	0.31	0.24	0.92	-0.26	0.94	-0.37	0.47	-0.38	-0.49	0.13		0.27
Reconciled Depreciation	1.0	0.86	0.04	0.99	0.99	0.99	0.99	0.2	0.51	0.94	0.79	0.99	0.18	-0.97	0.33	-0.86	0.86	-0.85	-0.76	0.17	0.27

Click cells to compare fundamentals

Mingchen Health Account Relationship Matchups

Mingchen Health income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	29.7M	43.5M	50.3M	175.3M	201.6M	211.7M
Interest Expense	2.2M	1.7M	1.9M	3.7M	4.2M	4.4M
Selling General Administrative	14.4M	19.3M	25.5M	24.7M	28.4M	18.6M
Selling And Marketing Expenses	74.7M	83.3M	321.0M	664.7M	764.4M	802.6M
Total Revenue	680.6M	744.1M	945.4M	1.6B	1.9B	2.0B
Gross Profit	288.9M	374.9M	496.3M	986.9M	1.1B	1.2B
Other Operating Expenses	567.6M	622.9M	956.8M	1.5B	1.8B	1.9B
Operating Income	105.2M	126.7M	16.8M	57.9M	66.6M	58.2M
Ebit	105.2M	126.7M	16.8M	103.3M	118.8M	64.5M
Ebitda	134.8M	170.2M	67.1M	278.7M	320.5M	336.5M
Cost Of Revenue	391.7M	369.2M	449.1M	650.7M	748.3M	425.0M
Total Operating Expenses	175.9M	253.7M	507.7M	884.9M	1.0B	1.1B
Income Before Tax	104.8M	127.5M	15.2M	56.6M	65.1M	58.7M
Total Other Income Expense Net	(389.4K)	760.4K	(1.6M)	(44.8M)	(40.3M)	(38.3M)
Net Income	102.2M	133.5M	25.4M	70.4M	80.9M	57.6M
Income Tax Expense	2.5M	(6.0M)	(10.1M)	(13.7M)	(12.4M)	(11.7M)
Research Development	46.3M	98.5M	110.3M	111.3M	128.0M	134.4M
Tax Provision	2.5M	(6.0M)	(10.1M)	(13.7M)	(12.4M)	(11.7M)
Net Interest Income	(436.6K)	328.8K	3.8M	(2.9M)	(2.6M)	(2.5M)
Interest Income	1.8M	3.2M	6.0M	1.1M	1.2M	2.1M
Net Income From Continuing Ops	102.2M	133.5M	25.3M	70.4M	80.9M	66.0M
Net Income Applicable To Common Shares	23.1M	102.2M	133.5M	25.3M	29.1M	27.7M
Reconciled Depreciation	12.4M	24.1M	50.3M	175.3M	201.6M	211.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Other Information on Investing in Mingchen Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mingchen Historical Income Statement

About Mingchen Income Statement Analysis

Mingchen Health Income Statement Chart

Total Revenue

Gross Profit

Mingchen Health income statement Correlations

Mingchen Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mingchen Health income statement Accounts

Also Currently Popular

Other Information on Investing in Mingchen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Depreciation And Amortization
Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Total Operating Expenses	+ 1.0	Gross Profit

Tax Provision	- 0.98	Research Development
Reconciled Depreciation	- 0.97	Total Other Income Expense Net
Total Other Income Expense Net	- 0.97	Depreciation And Amortization
Research Development	- 0.96	Income Tax Expense
Total Other Income Expense Net	- 0.96	Selling And Marketing Expenses
Total Other Income Expense Net	- 0.95	Total Operating Expenses